Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males or females between the ages of 18 and 70 years~* Body mass index (BMI) between 18 and 32 kg/m\^2, inclusive~* Females could not be pregnant or breast feeding and had to be using birth control~Exclusion Criteria:~* Positive drug screen for substances of abuse~* Positive results for HIV, hepatitis B, or hepatitis C~* Screening 12-lead ECG demonstrating QTc interval \>430 msec for males and \>450 msec for females, or any cardiac rhythm disorder considered by the Investigator to be clinically relevant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- CLP 15 g Fed (Type: EXPERIMENTAL): Cross-Linked Polyelectrolyte (CLP) Study medication delivered q.i.d just before each of 4 standardized meals/snack
- CLP 25 g Fed (Type: EXPERIMENTAL): Cross-Linked Polyelectrolyte (CLP) Study medication delivered q.i.d just before each of 4 standardized meals/snack
- CLP 7.5 g Fed (Type: EXPERIMENTAL): Cross-Linked Polyelectrolyte (CLP) Study medication delivered q.i.d just before each of 4 standardized meals/snack
- CLP 15 g fasted (Type: EXPERIMENTAL): Cross-Linked Polyelectrolyte (CLP) Study medication delivered q.i.d 1 hour prior to 4 standardized meals/snack

Based on this trial design, predict the completion outcome and termination type (if applicable).